SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: cirrus who wrote (40675)7/9/1999 10:55:00 AM
From: Anthony@Pacific  Read Replies (2) | Respond to of 122087
 
Yes I agree IMCL is the king of cancer stock pure plays



To: cirrus who wrote (40675)7/9/1999 10:46:00 PM
From: ACS_101  Respond to of 122087
 
IMCL's Phase II trials eradicated tumors in the majority of human subjects (I recall something like 13 out of 18).

Many small biotech's touting cancer cures are still testing on mice and are years away from a marketable treatment. IMCL, by contrast, is in Phase III and stands a decent chance for FDA fast track.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News